Interleukin (IL)-16, a CD4+ immune cell specific chemoattractant cytokine, has been shown to be involved in the development of multiple sclerosis, an inflammatory demyelinating disease of the central nervous system (CNS). While immune cells such as T cells and macrophages are reported to be the producers of IL-16, the cellular source of IL-16 in the CNS is less clear. This study investigates the correlation of IL-16 expression levels in the CNS with the severity of neuroinflammation and determines the phenotype of cells which produce IL-16 in the CNS of experimental autoimmune encephalomyelitis (EAE) mice. Our data show that IL-16 expression is significantly increased in the brain and spinal cord tissues of EAE mice compared to phosphate buffered saline (PBS) immunised controls. Dual immunofluorescence staining reveals that the significantly increased IL-16+ cells in the CNS lesions of EAE mice are likely to be the CD45+ infiltrating immune cells such as CD4+ or F4/80+ cells and the CNS resident CD11b+ microglia and GFAP+ astrocytes, but not NeuN+ neurons. Our data suggest cytokine IL-16 is closely involved in EAE pathology as evidenced by its increased expression in the glial and infiltrating immune cells, which impacts the recruitment and activation of CD4+ immune cells in the neuroinflammation.
Organoids are three-dimensional stem cell-derived structures that differentiate into multiple cell types. Their capacity to self-organize, coupled with the presence of diverse cell types, means that organoids resemble their organ of origin in architecture and function. Organoids from intestinal tissues have been extensively used as a three-dimensional model for in vitro studies of the gut. However, they typically self-organize with basal-out polarity when cultured in a three-dimensional extracellular matrix scaffold, presenting a hurdle for experiments that require access to the apical epithelial surface. Methods to invert the surface polarity of intestinal organoids have been reported, but little information exists on how this change of polarity impacts gene expression and cell populations present within the organoids. To address this knowledge gap, we modelled both polarity states in intestinal organoids from two different ruminant species. Apical-out organoids largely retained the same gene expression profile as basal-out organoids. Moreover, a combination of RNA-seq and immunohistochemistry analyses demonstrated the retention of specific markers of enterocytes, enteroendocrine, goblet and tuft cells present in organoids of both polarity states. This study presents a comprehensive validation of apical-out ileal organoids, providing supporting evidence for the utility of this model in experiments that require access to the apical surface.
The healthy equine stomach is of essential importance to equine digestive health and overall wellbeing. Diseases of the gastric mucosa such as gastric ulcers are highly prevalent in equids, particularly amongst racing thoroughbreds, and present a significant challenge to animal health and welfare. Despite this, there is currently no lab-based model capable of accurately representing the cellular diversity and cellular interactions within the equine gastric mucosa to aid in development of treatment options. We present here the first report of equine gastric organoids derived from glandular mucosa tissue. Through bulk RNA-sequencing and immunofluorescence we show these gastric organoids are representative of the tissue whilst retaining the individual gene-expression properties of the animal they were derived from. We also show these organoids are stable over multiple passages and can be differentiated towards different cell-types to upregulate protein and gene expression of specialised cell markers such as gastric foveolar cell associated mucin 5ac, gastrokine 1 & 2 and trefoil factor 2 . This model establishes the first physiologically relevant in vitro model of the equine gastric epithelium, representing a significant opportunity for developing understanding and therapeutic treatments of gastric diseases in equids.
An article published in 1992 by Marion M. Pollin and I.R. Griffiths reviewed the topic of primary dysautonomias of the autonomic nervous system of unidentified origin in multiple domestic species, specifically cats, dogs and horses. Thirty‐one years later, we appear no closer to identifying the causal agents of these strikingly similar diseases. This article reviews the similarities and differences in clinical presentation and pathology of dysautonomia in canids, felids, equids, leporids and other less frequently reported species.